Skip to content
Search

Latest Stories

7 more UK Universities seek accreditation for MPharm programmes amid staffing concerns

7 more UK Universities seek accreditation for MPharm programmes amid staffing concerns

The Pharmacy Schools Council is calling for urgent action to address rising alarms over severe staffing shortages that threaten the quality of education

The Pharmacy Schools Council (PhSC) has issued a statement urging a cautious approach to the significant expansion of additional UK universities seeking accreditation for new Master of Pharmacy (MPharm) programmes.

At least seven more UK universities are seeking accreditation for new Master of Pharmacy (MPharm) programmes, but existing pharmacy school heads are warning that severe staffing shortages could threaten the quality of education.


While the council welcomes the increasing interest in the pharmacy profession, it has warned that the "growth is managed not only in the workplace but within the

education sector."

In a meeting held in April 2024, the council members expressed that while this expansion would increase the number of undergraduate places available for pharmacy students, heads of existing pharmacy schools raised serious concerns about the challenges in recruiting suitably qualified staff to run these programmes.

The PhSC highlighted the difficulties in attracting candidates for academic positions, particularly those requiring clinical expertise.

"It is not uncommon for advertised posts to attract only one or two suitably qualified candidates and headhunting of existing members of the pharmacy academic workforce by

new and established SoPs is becoming an increasingly common occurrence," the Council stated.

The council also stated that the recruitment of practicing pharmacists is challenging, despite being essential for teaching the increasingly clinical components of the MPharm curriculum.

These pharmacists typically command salaries equivalent to Agenda for Change Band 8a in the NHS, which range from £50,952 to £57,349.

In contrast, higher education institutions (HEIs) are often pressured to manage with smaller staff bases or to offer positions at lower pay grades due to financial constraints, exacerbated by tuition fees that have remained stagnant since 2012.

The PhSC further emphasised the need to make academic pharmacy a more attractive career path and exploring alternative routes for career progression outside the traditional PhD pathway.

They also noted that universities are finding it increasingly difficult to retain staff, who are being approached by new SoPs with job offers.

The PhSC has called for greater investment from the NHS to support this expansion.

"The Pharmacy Schools Council recognises and welcomes the work currently being done by the Chief Pharmaceutical Officer for England’s office on enhancing clinical academic careers, but this does not address the current salary disparities between HEIs and the external workplace.

"We are therefore formally raising our concerns about the currently uncontrolled increase in schools of pharmacy in the UK without a commensurate investment from the NHS in any of the Home Nations in training at undergraduate level," the Council said.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less